Rate My Professor Thomas Nathow

Thomas Nathow graduated from the University of Leipzig in 1997 with a medical degree. He completed advanced training in Internal Medicine, obtaining further qualifications in sleep medicine and emergency medicine. After a voluntary year as Senior House Officer in the emergency departments of Caboolture Hospital and Redcliffe Hospital, he joined Ipswich General Hospital as Consultant Physician in General Medicine in 2008 and received Fellowship of the Royal Australasian College of Physicians in 2010. Practicing at Mater Private Hospital Springfield, his clinical interests encompass acute and subacute management of medical patients, diabetes, and endocrinology. He supervises junior doctors and third-year medical students from The University of Queensland. In 2014, he founded the Ipswich Research Institute to connect local patients with national and international research projects, collaborating with researchers and pharmaceutical companies. His contributions to research include co-authorship on clinical trials such as the BRIGHT study, 'Effect of Insulin Glargine Up-titration vs Insulin Degludec Once Daily on Glycemic Control Accompanying Treatment With Metformin in Type 2 Diabetes,' published in JAMA in 2016; a randomised, placebo-controlled clinical trial in Diabetologia in 2018; and a safety and pharmacodynamics study of temelimab in Diabetes, Obesity and Metabolism in 2020. These works demonstrate his impact on advancing diabetes management strategies.